1335213-37-0

Basic information

• Product Name: 6-{2-[2-(4-chloro-phenyl)-2,4,5,6-tetrahydro-cyclopentapyrazol-3-yl]-2-cyclohexyl-ethoxy}-nicotinic acid methyl ester
• Synonyms: 6-{2-[2-(4-chloro-phenyl)-2,4,5,6-tetrahydro-cyclopentapyrazol-3-yl]-2-cyclohexyl-ethoxy}-nicotinic acid methyl ester
• CAS NO: 1335213-37-0
• Molecular Weight: 480.007
• Mol File: 1335213-37-0.mol

Chemical Properties

• CAS DataBase Reference: 6-{2-[2-(4-chloro-phenyl)-2,4,5,6-tetrahydro-cyclopentapyrazol-3-yl]-2-cyclohexyl-ethoxy}-nicotinic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 6-{2-[2-(4-chloro-phenyl)-2,4,5,6-tetrahydro-cyclopentapyrazol-3-yl]-2-cyclohexyl-ethoxy}-nicotinic acid methyl ester(1335213-37-0)
• EPA Substance Registry System: 6-{2-[2-(4-chloro-phenyl)-2,4,5,6-tetrahydro-cyclopentapyrazol-3-yl]-2-cyclohexyl-ethoxy}-nicotinic acid methyl ester(1335213-37-0)

Safety Data

• Hazardous Substances Data: 1335213-37-0(Hazardous Substances Data)

Upstream product

• 147596-63-2 Ethyl hydrogen 2-cyclohexylpropanedioate 
• 66171-50-4 methyl 6-hydroxynicotinate 
• 1335213-36-9 methanesulfonic acid 2-[2-(4-chloro-phenyl)-2,4,5,6-tetrahydro-cyclopentapyrazol-3-yl]-2-cyclohexyl-ethyl ester 
• 1335213-32-5 2-[2-(4-chloro-phenyl)-2,4,5,6-tetrahydro-cyclopentapyrazol-3-yl]-2-cyclohexyl-ethanol 
• 1335213-31-4 [2-(4-chloro-phenyl)-2,4,5,6-tetrahydro-cyclopentapyrazol-3-yl]-cyclohexyl-acetic acid ethyl ester 
• 1335213-30-3 2-cyclohexyl-3-oxo-3-(2-oxo-cyclopentyl)-propionic acid ethyl ester 
• 409099-31-6 3-benzotriazol-1-yl-2-cyclohexyl-3-oxo-propionic acid ethyl ester 

Relevant articles and documents

CYCLOPENTYL- AND CYCLOHEPTYLPYRAZOLES

This invention relates to novel cyclopentyl- and cycloheptylpyrazole derivatives of the formula I wherein A and R1 to R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. The in

CYCLOPENTYL - AND CYCLOHEPTYLPYRAZOLES AS FXR MODULATORS

This invention relates to novel cyclopentyl- and cycloheptylpyrazole derivatives of the formula (I) wherein A and R1 to R4 are as defined in the description and in the claims, as well as physiologically acceptable salts thereof, to c